Shuttle Pharmaceuticals
SHPH
9 hedge funds and large institutions have $2.32M invested in Shuttle Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.27M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$815K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$692K |
| 4 |
Two Sigma Investments
New York
|
+$652K |
| 5 |
Millennium Management
New York
|
+$611K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $1.41M | +$6.27M | +154 | New |
|
|
2
Qube Research & Technologies (QRT)
London,
United Kingdom
| $179K | +$815K | +20 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $156K | +$692K | +17 | New |
|
|
4
Two Sigma Investments
New York
| $151K | +$652K | +16 | New |
|
|
5
Millennium Management
New York
| $137K | +$611K | +15 | New |
|
6
Jane Street
New York
| $96K | +$407K | +10 | New |
|
|
VF
7
Virtu Financial
New York
| $78K | +$367K | +9 | New |
|
8
HSBC Holdings
London,
United Kingdom
| $67K | +$285K | +7 | New |
|
9
Barclays
London,
United Kingdom
| $39K | +$163K | +4 | New |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.84K | – | – | – |
|
SHPH Hedge Fund Activity: Q3 2022 in Review
9 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q3 2022, worth a combined $2.32M.
Buyers outnumbered sellers: 9 funds opened new SHPH positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $6.27M.
- 9 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $2.32M of Shuttle Pharmaceuticals stock for Q3 2022.
- 9 funds opened new Shuttle Pharmaceuticals positions in Q3 2022 and 0 closed out, a net change of +9 holders.
- The largest Shuttle Pharmaceuticals buyer in Q3 2022 was BlackRock, an estimated $6.27M added.
Based on aggregated 13F filings for Q3 2022.